Publications by authors named "Per Holm"

Claim this Profile
D
Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system.
Ali El-Ayoubi, Arsen Arakelyan, Moritz Klawitter, Luisa Merk, Siras Hakobyan, Per Sonne Holm

Mol Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model.
Sebastian J Schober, Melanie Thiede, Hendrik Gassmann, Anna Josefine von Ofen, Pia Knoch, Per Sonne Holm

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells.
Anna Josefine von Ofen, Uwe Thiel, Jennifer Eck, Hendrik Gassmann, Melanie Thiede, Per Sonne Holm

Front Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal Delivery of Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends Survival of Glioblastoma-Bearing Mice.
Ali El-Ayoubi, Moritz Klawitter, Jakob Rüttinger, Giulia Wellhäusser, Per Sonne Holm

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Cell Cycle Facilitates E1A-Independent Adenoviral Replication.
Maximilian Ehrenfeld, Felicia Segeth, Klaus Mantwill, Corinna Brockhaus, Yuling Zhao, Per Sonne Holm

J Virol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.
Sebastian Johannes Schober, Caroline Schoening, Jennifer Eck, Charlotte Middendorf, Julia Lutsch, Per Sonne Holm

Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model.
Moritz Klawitter, Ali El-Ayoubi, Jasmin Buch, Jakob Rüttinger, Maximilian Ehrenfeld, Per Sonne Holm

Int J Mol Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus.
Jana Koch, Sebastian J Schober, Sruthi V Hindupur, Caroline Schöning, Florian G Klein, Per Sonne Holm

Nat Commun· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal treatment of cluster headache: A response.
Anja S Petersen, Mads C J Barloese, Per Holm, Rigmor H Jensen, Agneta H Snoer

Headache· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal ketamine for acute cluster headache attacks-Results from a proof-of-concept open-label trial.
Anja S Petersen, Adam S Pedersen, Mads C J Barloese, Per Holm, Ole Pedersen

Headache· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concepts in Oncolytic Adenovirus Therapy.
Klaus Mantwill, Florian Gerhard Klein, Dongbiao Wang, Sruthi Vasantamadhava Hindupur, Maximilian Ehrenfeld, Per Sonne Holm

Int J Mol Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.
Dirk M Nettelbeck, Mathias F Leber, Jennifer Altomonte, Assia Angelova, Julia Beil, Per Sonne Holm

Viruses· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer.
Florian G Klein, Charlène Granier, Yuling Zhao, Qi Pan, Zhichao Tong, Per Sonne Holm

J Pers Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy.
Sruthi V Hindupur, Sebastian C Schmid, Jana Annika Koch, Ahmed Youssef, Eva-Maria Baur, Per Sonne Holm

Int J Mol Sci· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irradiation enhances the therapeutic effect of the oncolytic adenovirus XVir-N-31 in brain tumor initiating cells.
Rebecca Czolk, Niklas Schwarz, Henner Koch, Sonja Schötterl, Thomas V Wuttke, Per S Holm

Int J Mol Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional genomics identifies predictive markers and clinically actionable resistance mechanisms to CDK4/6 inhibition in bladder cancer.
Zhichao Tong, Anuja Sathe, Benedikt Ebner, Pan Qi, Christian Veltkamp, Per Sonne Holm

J Exp Clin Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer.
Eva Lichtenegger, Florestan Koll, Helena Haas, Klaus Mantwill, Klaus-Peter Janssen, Per Sonne Holm

Hum Gene Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[2017 ESC/EACTS Guidelines for the management of valvular heart disease].
Helmut Baumgartner, Volkmar Falk, Jeroen J Bax, Michele De Bonis, Christian Hamm, Per Johan Holm

Kardiol Pol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.
Helmut Baumgartner, Volkmar Falk, Jeroen J Bax, Michele De Bonis, Christian Hamm, Per Johan Holm

Rev Esp Cardiol (Engl Ed)· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirus Particle Quantification in Cell Lysates Using Light Scattering.
Adrian Hohl, Anne Sophie Ramms, Christian Dohmen, Klaus Mantwill, Andrea Bielmeier, Per Sonne Holm

Hum Gene Ther Methods· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virotherapy Research in Germany: From Engineering to Translation.
Guy Ungerechts, Christine E Engeland, Christian J Buchholz, Jürgen Eberle, Henry Fechner, Per Sonne Holm

Hum Gene Ther· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2017 ESC/EACTS Guidelines for the management of valvular heart disease.
Volkmar Falk, Helmut Baumgartner, Jeroen J Bax, Michele De Bonis, Christian Hamm, Per Johan Holm

Eur J Cardiothorac Surg· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664].
Volkmar Falk, Helmut Baumgartner, Jeroen J Bax, Michele De Bonis, Christian Hamm, Per Johan Holm

Eur J Cardiothorac Surg· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2017 ESC/EACTS Guidelines for the management of valvular heart disease.
Helmut Baumgartner, Volkmar Falk, Jeroen J Bax, Michele De Bonis, Christian Hamm, Per Johan Holm

Eur Heart J· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses.
Guy Ungerechts, Sascha Bossow, Barbara Leuchs, Per S Holm, Jean Rommelaere

Mol Ther Methods Clin Dev· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis